May 23, 2018 7:02 AM ET

Biotechnology

Company Overview of TaiRx, Inc.

Company Overview

TaiRx, Inc., a pharmaceutical company, focuses on the development of therapeutics with unmet medical needs. The company’s products under development include CVM-1118, an oral anti-cancer drug that is Phase I clinical trial; and Rexis, an add-on injection therapy that is in Phase III clinical trials to treat patients with sepsis. Its pre-clinical products comprise TRX-606 that is used to enhance the drug absorption. The company was founded in 2011 and is based in Taipei City, Taiwan.

No. 66, San-Chung Road

7th Floor-5

Nankang Business Park

Taipei City,  11502

Taiwan

Founded in 2011

Phone:

886 2 2653 5007

Fax:

886 2 2653 5008

Key Executives for TaiRx, Inc.

TaiRx, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
ACRO Biomedical Co., Ltd. Asia
Advanced Gene Technology Corporation Asia
Akribio Co., Ltd. Asia
Aprinoia Therapeutics Inc. Asia
Asia Celera Genomics Corp. Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TaiRx, Inc., please visit www.trx.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.